TI
TBPH icon

Trexquant Investment’s Theravance Biopharma TBPH Stock Holding History

Trexquant Investment’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Sell
76,469
-129,315
-63% -$2.14M 0.01% 1371
2026
Q1 		$3.34M Buy
205,784
+23,294
+13% +$412K 0.02% 812
2025
Q4 		$3.41M Buy
182,490
+37,957
+26% +$630K 0.03% 768
2025
Q3 		$2.11M Sell
144,533
-12,397
-8% -$157K 0.02% 888
2025
Q2 		$1.73M Sell
156,930
-8,494
-5% -$82.6K 0.02% 931
2025
Q1 		$1.48M Buy
165,424
+14,341
+9% +$133K 0.02% 970
2024
Q4 		$1.42M Buy
151,083
+50,826
+51% +$462K 0.02% 983
2024
Q3 		$808K Buy
100,257
+66,735
+199% +$578K 0.01% 1110
2024
Q2 		$284K Buy
+33,522
New +$303K ﹤0.01% 1374
2023
Q1 		– Sell
-18,705
Closed -$210K – 1763
2022
Q4 		$210K Buy
+18,705
New +$197K 0.01% 1228
2022
Q1 		– Sell
-20,729
Closed -$229K – 1719
2021
Q4 		$229K Buy
+20,729
New +$181K 0.01% 1071
2020
Q4 		– Sell
-13,167
Closed -$195K – 1473
2020
Q3 		$195K Buy
13,167
+2,041
+18% +$38.2K 0.01% 1085
2020
Q2 		$234K Buy
+11,126
New +$286K 0.02% 990
2016
Q4 		– Sell
-5,995
Closed -$217K – 1127
2016
Q3 		$217K Sell
5,995
-6,061
-50% -$169K 0.05% 606
2016
Q2 		$274K Buy
+12,056
New +$260K 0.04% 689
2015
Q4 		– Sell
-55,000
Closed -$604K – 1251
2015
Q3 		$604K Buy
+55,000
New +$700K 0.05% 645

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Trexquant Investment's TBPH Position: Q2 2026 in Review

Trexquant Investment reduced its Theravance Biopharma (TBPH) stake by 63% in Q2 2026, selling an estimated $2.14M and leaving 76,469 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #1371.

Trexquant Investment first reported a position in TBPH in Q3 2015 and has held it in 16 quarters since. The position peaked at $3.41M in Q4 2025. 181 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Trexquant Investment held 76,469 shares of Theravance Biopharma worth $1.3M as of Q2 2026.
  • Trexquant Investment sold 129,315 Theravance Biopharma shares in Q2 2026, an estimated $2.14M.
  • Theravance Biopharma made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1371 holding.
  • Trexquant Investment first reported a position in Theravance Biopharma in Q3 2015 and has held it in 16 quarters since.
  • Trexquant Investment's Theravance Biopharma position peaked at $3.41M in Q4 2025.
  • 181 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.